Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa

Author:

Sun KaiyuanORCID,Tempia Stefano,Kleynhans JackieORCID,von Gottberg AnneORCID,McMorrow Meredith L.,Wolter NicoleORCID,Bhiman Jinal N.ORCID,Moyes Jocelyn,Carrim Maimuna,Martinson Neil A.,Kahn KathleenORCID,Lebina Limakatso,du Toit Jacques D.ORCID,Mkhencele Thulisa,Viboud CécileORCID,Cohen CherylORCID,Buys Amelia,de Gouveia Linda,du Plessis Mignon,Gómez-Olivé Francesc Xavier,Kgasago Kgaugelo Patricia,Kotane Retshidisitswe,Moloantoa Tumelo,Tollman Stephen,Wafawanaka Floidy,

Abstract

AbstractSouth Africa was among the first countries to detect the SARS-CoV-2 Omicron variant. However, the size of its Omicron BA.1 and BA.2 subvariants (BA.1/2) wave remains poorly understood. We analyzed sequential serum samples collected through a prospective cohort study before, during, and after the Omicron BA.1/2 wave to infer infection rates and monitor changes in the immune histories of participants over time. We found that the Omicron BA.1/2 wave infected more than half of the cohort population, with reinfections and vaccine breakthroughs accounting for > 60% of all infections in both rural and urban sites. After the Omicron BA.1/2 wave, we found few (< 6%) remained naïve to SARS-CoV-2 and the population immunologic landscape is fragmented with diverse infection/immunization histories. Prior infection with the ancestral strain, Beta, and Delta variants provided 13%, 34%, and 51% protection against Omicron BA.1/2 infection, respectively. Hybrid immunity and repeated prior infections reduced the risks of Omicron BA.1/2 infection by 60% and 85% respectively. Our study sheds light on a rapidly shifting landscape of population immunity in the Omicron era and provides context for anticipating the long-term circulation of SARS-CoV-2 in populations no longer naïve to the virus.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary

Reference52 articles.

1. Tracking SARS-CoV-2 variants, (available at https://www.who.int/activities/tracking-SARS-CoV-2-variants).

2. CoVariants, (available at https://covariants.org/).

3. Obermeyer, F. et al. Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness. Science 376, 1327–1332 (2022).

4. Telenti, A., Hodcroft, E. B., Robertson, D. L. The Evolution and Biology of SARS-CoV-2 Variants. Cold Spring Harb. Perspect. Med. 12 (2022), https://doi.org/10.1101/cshperspect.a041390.

5. the Nextstrain team, Genomic epidemiology of novel coronavirus - Global subsampling. Nextstrain https://nextstrain.org/ncov/gisaid/global (2022).

Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3